Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Obstructive sleep apnea and neurodegenerative diseases: A bidirectional relation.

Bahia CMCDS, Pereira JS.

Dement Neuropsychol. 2015 Jan-Mar;9(1):9-15. doi: 10.1590/S1980-57642015DN91000003. Review.

2.

Treatment of vascular dementia. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology.

Brucki SMD, Ferraz AC, de Freitas GR, Massaro AR, Radanovic M, Schultz RR; Working Group on Alzheimer's Disease and Vascular Dementia of the Brazilian Academy of Neurology.

Dement Neuropsychol. 2011 Oct-Dec;5(4):275-287. doi: 10.1590/S1980-57642011DN05040005. Review.

3.

Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms.

Lanctôt KL, Amatniek J, Ancoli-Israel S, Arnold SE, Ballard C, Cohen-Mansfield J, Ismail Z, Lyketsos C, Miller DS, Musiek E, Osorio RS, Rosenberg PB, Satlin A, Steffens D, Tariot P, Bain LJ, Carrillo MC, Hendrix JA, Jurgens H, Boot B.

Alzheimers Dement (N Y). 2017 Aug 5;3(3):440-449. doi: 10.1016/j.trci.2017.07.001. eCollection 2017 Sep. Review.

4.

Impact of Alzheimer disease patients' sleep disturbances on their caregivers.

Gehrman P, Gooneratne NS, Brewster GS, Richards KC, Karlawish J.

Geriatr Nurs. 2017 Jul 3. pii: S0197-4572(17)30156-8. doi: 10.1016/j.gerinurse.2017.06.003. [Epub ahead of print]

PMID:
28684102
5.

Chronic intermittent hypoxia induces oxidative stress and inflammation in brain regions associated with early-stage neurodegeneration.

Snyder B, Shell B, Cunningham JT, Cunningham RL.

Physiol Rep. 2017 May;5(9). pii: e13258. doi: 10.14814/phy2.13258.

6.

Treatment of intermittent hypoxia increases phosphorylated tau in the hippocampus via biological processes common to aging.

Yagishita S, Suzuki S, Yoshikawa K, Iida K, Hirata A, Suzuki M, Takashima A, Maruyama K, Hirasawa A, Awaji T.

Mol Brain. 2017 Jan 5;10(1):2. doi: 10.1186/s13041-016-0282-7.

7.

Emerging co-morbidities of obstructive sleep apnea: cognition, kidney disease, and cancer.

Gildeh N, Drakatos P, Higgins S, Rosenzweig I, Kent BD.

J Thorac Dis. 2016 Sep;8(9):E901-E917. Review.

8.

Trends in CPAP adherence over twenty years of data collection: a flattened curve.

Rotenberg BW, Murariu D, Pang KP.

J Otolaryngol Head Neck Surg. 2016 Aug 19;45(1):43. doi: 10.1186/s40463-016-0156-0. Review.

9.

Treatment of Sleep Disorders in Dementia.

Ooms S, Ju YE.

Curr Treat Options Neurol. 2016 Sep;18(9):40. doi: 10.1007/s11940-016-0424-3. Review.

10.

Obstructive Sleep Apnea and Cognition in Parkinson's disease.

Harmell AL, Neikrug AB, Palmer BW, Avanzino JA, Liu L, Maglione JE, Natarajan L, Corey-Bloom J, Loredo JS, Ancoli-Israel S.

Sleep Med. 2016 May;21:28-34. doi: 10.1016/j.sleep.2016.01.001. Epub 2016 Feb 10.

11.

Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease?

Mander BA, Winer JR, Jagust WJ, Walker MP.

Trends Neurosci. 2016 Aug;39(8):552-66. doi: 10.1016/j.tins.2016.05.002. Epub 2016 Jun 17. Review.

12.

Sleep Pathology in Creutzfeldt-Jakob Disease.

Kang P, de Bruin GS, Wang LH, Ward BA, Ances BM, Lim MM, Bucelli RC.

J Clin Sleep Med. 2016 Jul 15;12(7):1033-9. doi: 10.5664/jcsm.5944.

13.

The Association Between Obstructive Sleep Apnea and Alzheimer's Disease: A Meta-Analysis Perspective.

Emamian F, Khazaie H, Tahmasian M, Leschziner GD, Morrell MJ, Hsiung GY, Rosenzweig I, Sepehry AA.

Front Aging Neurosci. 2016 Apr 12;8:78. doi: 10.3389/fnagi.2016.00078. eCollection 2016.

14.

Different cyclical intermittent hypoxia severities have different effects on hippocampal microvasculature.

Lim DC, Brady DC, Soans R, Kim EY, Valverde L, Keenan BT, Guo X, Kim WY, Park MJ, Galante R, Shackleford JA, Pack AI.

J Appl Physiol (1985). 2016 Jul 1;121(1):78-88. doi: 10.1152/japplphysiol.01040.2015. Epub 2016 Apr 28.

15.

Sleep disordered breathing at the extremes of age: the elderly.

McMillan A, Morrell MJ.

Breathe (Sheff). 2016 Mar;12(1):50-60. doi: 10.1183/20734735.003216. Review.

16.

Reconsidering first-line treatment for obstructive sleep apnea: a systematic review of the literature.

Rotenberg BW, Vicini C, Pang EB, Pang KP.

J Otolaryngol Head Neck Surg. 2016 Apr 6;45:23. doi: 10.1186/s40463-016-0136-4. Review.

17.

Clinical management of sleep disturbances in Alzheimer's disease: current and emerging strategies.

Urrestarazu E, Iriarte J.

Nat Sci Sleep. 2016 Jan 14;8:21-33. doi: 10.2147/NSS.S76706. eCollection 2016. Review.

18.

The Role of Sleep and Sleep Disorders in the Development, Diagnosis, and Management of Neurocognitive Disorders.

Miller MA.

Front Neurol. 2015 Oct 23;6:224. doi: 10.3389/fneur.2015.00224. eCollection 2015. Review.

19.

The Interaction between Obstructive Sleep Apnea and Parkinson's Disease: Possible Mechanisms and Implications for Cognitive Function.

Kaminska M, Lafontaine AL, Kimoff RJ.

Parkinsons Dis. 2015;2015:849472. doi: 10.1155/2015/849472. Epub 2015 Oct 5. Review.

20.

New developments in the use of positive airway pressure for obstructive sleep apnea.

Donovan LM, Boeder S, Malhotra A, Patel SR.

J Thorac Dis. 2015 Aug;7(8):1323-42. doi: 10.3978/j.issn.2072-1439.2015.07.30. Review.

Supplemental Content

Support Center